What's new this month in BMJ JournalsBMJ 2006; 332 doi: http://dx.doi.org/10.1136/bmj.332.7539.476 (Published 23 February 2006) Cite this as: BMJ 2006;332:476
- Harvey Marcovitch, syndication editor ([email protected])
Statins benefit community patients
Statins have proved beneficial in community based patients with ischaemic heart disease, discounting the suggestion that they might be disproportionately effective when prescribed as part of a controlled trial. Evidence comes from an eight year follow-up among 1.18 million patients registered with 89 UK general practices. A first diagnosis of ischaemic heart disease (IHD) was made in 13 029 patients, of whom 2266 died. Patients with IHD who were prescribed statins had a 39% lower risk of death than those who were not. Benefit was seen within two years of treatment and also affected women, diabetic patients, and elderly people. Risk of death was reduced by 19% for each additional year of treatment. The authors claim that since community based patients are likely to have a higher risk than those entered into controlled …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial